Clinical Trials Browser

OTHER × Has results × nintedanib × Clear all

NCT03377023 2026-04-02

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

Phase 1/2 Active not recruiting

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT02299141 2025-06-24

Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

20 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT02496585 2025-04-16

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Phase 2 Completed

34 enrolled 10 charts

Lung Neoplasms, Radiation Pneumonitis

NCT02902484 2024-06-03

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

Phase 1/2 Terminated

14 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02399215 2023-12-26

Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Phase 2 Completed

32 enrolled 12 charts

Carcinoid Tumor, Neuroendocrine Tumors

NCT03287947 2022-08-09

LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

Phase 2 Terminated

5 enrolled 12 charts

Gastrointestinal

Appendiceal Neoplasms

NCT02665143 2022-04-08

A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia

Phase 2 Completed

25 enrolled 7 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02568449 2021-12-09

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

Phase 2 Completed

20 enrolled 11 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02393755 2021-07-08

Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer

Phase 1/2 Completed

42 enrolled 16 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT02234596 2021-01-25

Nintedanib in Patients With Advanced Esophagogastric Cancer

Phase 2 Completed

34 enrolled 9 charts

Gastrointestinal

Esophagogastric Adenocarcinoma

NCT02452463 2020-04-06

Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

Phase 2 Terminated

8 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT02389764 2019-07-17

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

Phase 2 Terminated

10 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01669798 2018-10-16

BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer

Phase 2 Completed

32 enrolled 19 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01948141 2017-06-08

Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

Phase 2 Completed

6 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT01380782 2014-08-18

BIBF 1120 for Recurrent High-Grade Gliomas

Phase 2 Completed

37 enrolled 11 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Recurrence, Gliosarcoma